The low-affinityIgGreceptor,Fc γ RIIA, hasbeen implicated in Streptococcus sanguis -induced plateletaggregation.Therefore,it islikelyt hats ignaltransduction isatleast partlymediated by Fcγ RIIA activationand atyrosine kinase-dependentpathway.In thiss tudyt he signaltransduction mechanismsassociated with plateletactivation in responsetothe oralbacterium, S.sanguis werecharacterised.Inthe presenceo fIgG, S.sanguis strain 2017-78caused the tyrosine phosphorylationo fFcγ RIIA 30s following stimulation,whichled tothe phosphorylationofSyk, LAT, and PLC γ 2.Thesee arlyevents wered ependenton Src familykinasesbut independentof eitherTxA 2 ort he engagementof the α IIb β 3 integrin.During the lagphasepriortoplatelet aggregation,Fc γ RIIA, Syk,LAT,and PLCγ 2w eree achd ephosphorylated,b ut werere-phosphorylated asaggregation occurred.Platelets timulation by2 017-78alsoi nduced the tyrosine phosphorylationofPECAM-1,anITIM-containing receptor Keywords Fcγ RIIA, platelet,PECAM-1,SHP-1, Streptococcus sanguis thatr ecruits protein tyrosine phosphatases.PECAM-1 co-precipitated withthe protein tyrosine phosphataseSHP-1 in the lag phase. SHP-1 wasalsomaximallytyrosine phosphorylated during thisphase,suggestingapossible role forSHP-1 in the observed dephosphorylatione vents.Asaggregation occurred,SHP-1 wasdephosphorylated,while Fcγ RIIA, Syk,L AT,a nd PLCγ 2 wererephosphorylated in anRGDS-sensitive,a nd therefore α IIb β 3 -dependent,manner.Additionally,TxA 2 release,5-hydroxytryptaminesecretion and phosphatidica cid formation were all blockedbyRGDS.Aspirin alsoabolishedthesee vents,but onlypartiallyinhibited α IIb β 3 -mediated re-phosphorylation. Therefore, S.sanguis -bound IgGcross linksFcγ RIIA and initiates asignaling pathwaythatisdown-regulated byPECAM-1-bound SHP-1.Subsequentengagementof α IIb β 3 leadstoSHP-1 dephosphorylationpermitingasecond waveofsignaling leadingtoTxA 2 releaseand consequentplateletaggregation.
Introduction
Severalstudieshavesuggested thatorali nfections,most commonlymanifested in periodontaldisease,arerelated tothe incidenceofcertain cardiovasculardiseasesincludingatherosclerosisandmyocardialinfarction (1) (2) (3) .Inaddition,theincidenceof myocardiali nfarction and strokei ncreasesduring acutei nfections (4) ,and severalviraland bacterialinfectionsarepositive riskfactors in susceptible individuals (5) (6) (7) .
Streptococcus sanguis ( S.sanguis ),agram-positiveoralbacterium,b indst oand activatesplatelets in vitro (8) (9) (10) and has beenshowntop recipitatem yocardiali nfarction,thrombocytopeniaand pulmonary plateletaccumulation in rabbits (11) (12) (13) . Them echanismsu nderlying S.sanguis -induced plateletactivation havebeen partiallycharacterized.Forexample,thecollagen receptor α 2 β 1 (14) ,the von Willebrand factorreceptorsubunitGPIb (15, 16) ,complementproteinson the bacterialsurface (17) ,the interaction of plasma-derived IgGwiththe plateletFc receptor (18) ,and the cyclooxygenase/thromboxane A 2 (TxA 2 ) pathway(9,10)haveeachbeensuggested tomediateplatelet-S. sanguis interaction and/or S.sanguis -induced plateletaggregation.
Ofparticularinterest isthe potentialroleplayed byFcγ RIIA, the plateletlow-affinity IgGreceptor,in the plateletresponseto S.sanguis .Specificantibodiesin plasmabind tobacterialsurfaces,a nd the Fc portion of theseantibodiesinteractw ith Fcγ RIIA toi nitiatep lateletactivation (19) . Indeed,removalo f IgGfromplasmaorpre-treatmentof platelets withIV.3,amonoclonalantibodyt hatblocksIgGb indingtoFcγ RIIA, prevents plateletaggregation to S.sanguis (9, 18) ,demonstrating a requirementforFcγ RIIA activation.
Directcross-linking and activation of Fcγ RIIA using anantiFcγ RIIA antibodyand F(ab')2fragments causesr apidp latelet activation and aggregation (20) . Intracellularsignallinginitially involvesthe Srcfamilykinase-mediated phosphorylation of tyrosine residueswithin the immunoreceptortyrosine-basedactivation motif (ITAM)inthe cytoplasmicdomain of Fcγ RIIA (21, 22) . Thisallows fort he non-covalentengagementof SH2do-main-containing proteinssuchasthe tyrosine kinaseSyk (23) , whichi scrucialf orevents thatleadtop hospholipaseC γ 2 (PLC γ 2)phosphorylation (24) (25) (26) . PLC γ 2isacentralenzyme in earlyFcγ RIIA signaling asitinducesthe production of the second messengers inositol (1,4,5)-trisphosphate(IP 3 )and diacylglycerol (DAG) ( 27) ,leading tosecretion and aggregation responses.
UnlikedirectFcγ RIIA cross-linking,plateletaggregation induced by S.sanguis istypified byalong lagphasepriortorapid aggregation (8) (9) (10) . Therefore,inhibitory mechanismsmaybe activated thatopposethe Fcγ RIIA-mediated response. Studiesin immune cellss uggest thatITAM-containing receptort yrosine kinasepathways mayberegulated byimmunoreceptortyrosinebasedinhibitory motif (ITIM)-containing receptors,whichcan recruitinhibitory phosphatasess uchast he protein tyrosine phosphatases(PTP)SH2domain-containing protein tyrosine phosphatase-1( SHP-1) and SHP-2,a nd the lipidp hosphatases SH2domain-containing inositol phosphatase-1( SHIP-1) and SHIP-2 (28) . Platelets possess the platelet-endothelialcelladhesion molecule-1 (PECAM-1),a130-kDmembrane glycoproteinthatiscurrentlythe onlyknownITIM-containing receptor on the plateletsurface (29) . Its directactivation bycross-linking agents inducest he association of SHP-1 and/orSHP-2and inhibits plateletaggregation in responsetocollagen and Fcγ RIIA activation (30) (31) (32) (33) .
Inthepresentstudy,wehaveinvestigated signaling pathways triggered in platelets bythe S.sanguis strain,2017-78. Fcγ RIIA cross-linkingand activation initiatesanearlysignalingpathway involving the tyrosine phosphorylation of severalp lateletproteinsthatisnegativelyregulated byPECAM-1 and its associated PTP, SHP-1. α IIb β 3 activation mediatesasecondwaveoftyrosine phosphorylation thatleadstothe production of secondary messengers necessary foraggregation. 
Materialsand methods

Preparationofplatelet-richplasma(PRP)
The studyw asapproved byt he ResearchEthicsBoardo fthe University of Manitoba.Bloodwasdrawnbyvenipuncturefrom healthy,c onsenting adults who hadd enied taking anymedicationsknowntointerferewithplateletfunction within the previous twoweeks.Itwasmixed with0.1xvolume of 3.8% sodium citrateand centrifugedat200 x g for20min atroom temperature toobtain PRP.Platelets wereallowed toequilibratefor30min at 37°Cpriort ouse. Presented resultsarerepresentativeo f2-3 similarexperiments using blood from differentdonors.
PreparationofIgG-free PRP
IgGwasdepletedfrom plasmabyaffinity chromatographyusing ProteinAc oated-sepharosebeads.The columnwasinitially eluted withwashbuffer(100mMTris,pH7.5,1.5 mMNaCl), followed byHepesTyrodesbuffer.Platelet-poorplasma(PPP), whichwaspreparedbycentrifugation of 1m La liquots of citrated PRP at2000 x g for3min,wassubsequentlyappliedtothe column. Thefirst 0.5mLof eluatewasdiscardedand the next 1.5-2mLcollectedintoanEppendorftubeand stored at37°C until use. 0.5 mLaliquots of acidifiedPRP werecentrifuged(2000 x g , 3min) toobtain plateletpellets.Plasmawasaspirated,platelets wereresuspended in 0.5 mLof IgG-depleted PPPand allowed to equilibrateat37°Cfor30min priortouse.
Plateletaggregation
Aggregation of platelets (2.5x10 8 platelets/mL)wascarriedout in aPayton dualchannel aggregometeraspreviouslydescribed (34) . S.sanguis strain 2017-78wasadded toPRP ata1:2platelet tobacteriaratio.
Immunoprecipitation
Reactionswerestoppedbythe addition of anequalvolume of 2x stopping solution (20 mMEDTA, 6mMNa 3 VO 4 ,20 µ Mstaurosporine) (35) .Platelets werepelleted bycentrifugation at8500 xgfor30s,sonicated 4x10sin cold2x RIPAbuffer(36)or1x lysisbuffer(37)(forPECAM-1 immunoprecipitation) and lysed for30min at4°C.The lysatewascentrifugedat12000 x g for10 min at4°C,and the supernatantwasprecleared withProteinA/G PLUS agarosebeads.Lysatesw ereincubated overnightat4°C withanti-PLCγ 2Ab (2.5 µ g/mL),a nti-LATA b(2.5 µ g/mL), anti-PECAM-1 Ab (10 µ g/mL),oranti-SHP-1 Ab (2.5 µ g/mL), orfor90min at4°Cwithanti-Syk(LR)Ab (2.5 µ g/mL)orIV.3 mAb (2.5 µ g/mL),thenagarosebeadsw ereadded forafurther 60 min. The beadswereisolated bycentrifugation and washed3 timeswith1xRIPA washbufferorPBS (forPECAM-1 immunoprecipitations). The proteinsw eree luted byboiling withreducing bufferfor10minutes,separated by7.5 or10%SDS-polyacrylamide gelsand immunoblotted forphosphotyrosine with the mAb 4G10according tothe method of ClarkandBrugge (36) .Proteinswerevisualized withacommercialECL kit.
Blotsweresubsequentlystrippedwith0.1 MNaCland 0.1M glycine (pH2.2),washedwithTBS-Tween,and re-probed with the appropriateantibodytoensureeven loading among lanesor todetectforco-precipitation.
Thromboxane B 2 release 2017-78wasadded toPRP and reactionsterminated atthe point of full aggregation bythe addition of anequalvolume of icecold acid/citrate/dextroseanticoagulant(ACD) ( 34) . Platelets were pelletedbycentrifugation at8500 x g for30sand the supernatantfrome achsample wascollected intoseparateEppendorf tubes.Levelsof released TxB 2 wered etected using aT xB 2 enzyme immunoassaykitaccording tothe manufacturer'sinstructions. 
Phosphatidicacid formation
Equalquantitiesof blood weredrawninto0.1xvolume of 3.8% sodiumcitrateand 0.18xv olume of acid-citrate-dextrose. PRP wasobtained asoutlined above. Platelets werepelleted byfurther centrifugation at800 x g for15 min atr oom temperature. Citrated PPP wasstored at37°Cuntilused. The plateletpelletfrom acidifiedPRP wasresuspendedin1-2mLof PO 4 -free HepesTyrodesbuffer(150mMNaCl,4mMKCl,1mMMgCl 2 ,5mM HEPES,10mMdextrose,0.3%bovine serumalbumin;pH7.4) and incubated with1 00 -1 20 µ Ci[ 32 P]-ortho-phosphatef or1 hour at3 7°C.Platelets werei solated bycentrifugation,resuspendedincitrated PPP and allowed toequilibratefor30min at 37°Cpriort ouse. Undert hesel abelling conditions,the formation of [ 32 P]-phosphatidica cid isr egarded asani ndexof phosphoinositide-specificphospholipaseCactivity (38) .
Plateletaggregation in responseto S.sanguis wascarriedout asoutlined above,terminated,phospholipidsextracted and separatedbyt hin-layerchromatographyasdescribedp reviously (39 
Results
2017-78inducesplateletaggregationand Fcγ RIIA tyrosinephosphorylationinanIgG-dependentmanner
Humanp latelets aggregatef ollowing challenge by S.sanguis strain 2017-78,a shasbeen shownp reviously (8) . Therei sa donordependentlagphasepriortothe onsetof aggregation with maximumaggregation occurring at12.1±1.6min (rangefrom 5 to19min;n=10).Aspreviouslydemonstrated(9,10), S.sanguisinduced plateletaggregation iss ensitivetop re-treatmentw ith aspirin (100 µΜ; 30 min) orRGDS (1 mM;5min) and istherefored ependenton TxA 2 production and fibrinogen binding to α IIb β 3 (datanotshown).Duetothe significantdonorvariability in the lagp hasep riort othe onsetof aggregation,in the subsequentstudiesprotein phosphorylation status wasdetermined atpoints corresponding tothe lagphase,the start of aggregation, mid-aggregation and full aggregation fort hats pecificdonor (Fig. 1) .
Asoutlined above,I gGa nd the activation of its receptor, Fcγ RIIA, areessentialforplateletaggregation in responsetoviridansgroupstreptococci ( 18) . Inthep resents tudy,pre-incubation of platelets withthe anti-Fcγ RIIA mAb IV.3(2.5 µ g/mL; 1min) ordepletion of plasmaIgGinhibits 2017-78-induced aggregation,confirming thataggregation in responsetothisstrain requiresFcγ RIIA cross-linkingbyIgG(datanotshown).
The addition of 2017-78,in the presenceofIgG,causesthe tyrosine phosphorylation of Fcγ RIIA.Phosphorylation occurs within30 sof the addition of 2017-78,decreasesin the lagphase priortoaggregation and subsequentlyincreasesasaggregation progresses( Fig. 2A) .
Tyrosine phosphorylation of Fcγ RIIA occurs in the intracellularITAM domain,likelyduetothe actionsof Srcfamilytyrosine kinases,suchasSrcand Lyn (21) . Pre-treatmentof platelets withthe SrcfamilykinaseinhibitorPP1(40),whichblocksthe activitiesof Lck,Lyn,Srcand Hck,inhibits plateletaggregation in responseto2017-78inadose-dependentmanner (Fig. 2B) .
2017-78inducesthe tyrosinephosphorylationof severalproteins
DirectFcγ RIIA cross-linkingand activation isassociated with the recruitment,phosphorylation and activation of avariety of signaling molecules,includingSyk,L AT,P I3-Ka nd PLCγ 2 (41). Inthe presentstudy,plateletactivation followingthe addition of 2017-78involvesSyk,LAT,and PLCγ 2tyrosine phosphorylation (Fig. 3A) withsimilartime coursestothatseen for Fcγ RIIA phosphorylation ( Fig. 2A) .
Depletion of IgGfromp lasmab locks2 017-78-induced phosphorylation of PLCγ 2( Fig. 3B) and LAT (Fig. 3C) ,consistentwithFcγ RIIA cross-linkinginitiating the signaling pathway, ashaspreviouslybeenreported forIgGcrosslinking. Figure3:Activationofhumanplatelets with2017-78induces the tyrosine phosphorylationofseveralproteins. A). Platelets werestirred with2017-78forthe timesindicated and reactionsterminated.Syk(i),LAT (ii),and PLCγ -2(iii) wereisolated byimmunoprecipitation,and tyrosine phosphorylationwasmonitored byimmunoblotting using 4G10.Blots werestripped andreprobed withthe appropriateantibodytoconfirmequalloading (lowerpanel).Labelsbelowthe upper blotrefertoaggregationstatus.Experiments arerepresentativeofthree similarexperiments using differentdonors.B). Platelets wereuntreated ori) depleted of IgG, ii) treated withPP1(5min;30 µ M),iii) RGDS (5 min;1mM),oriv)aspirin (20 min;100 µ M)priortostimulation with 2017-78for1min. PLCγ -2wasisolated byimmunoprecipitation,and tyrosinephosphorylationwasmonitored byimmunoblotting using 4G10 (upperpanels). The blotwasstripped and re-probed withanti-PLCγ 2 antibodytoconfirmequalloading (lowerpanels). Experiments arerepresentativeoftwotothree similarexperiments using differentdonors. C). Platelets wereuntreated ori) depleted of IgGpriortostimulation with2017-78for1min. LATwasisolated byimmunoprecipitation,and tyrosine phosphorylationwasmonitored byimmunoblotting using 4G10 (upperpanel).The blotwasstripped and re-probed withanti-LATantibodytoconfirmequalloading (lowerpanel).Experimentisrepresentativeofthree similarexperiments using differentdonors.
Pretreatmentof platelets withPP1 (Fig. 3B ),but withneither aspirin (Fig.3B)norRGDS (Fig. 3B) ,inhibited the earlyphosphorylation of PLCγ 2.Takentogetherthesedatasuggesting that Srcfamilykinasesplayaroleinthe activation pathway,and that the pathwayisactivated priorto,orindependentlyof,TxA 2 synthesisoraggregation.
2017-78inducesPECAM-1 and SHP-1 phosphorylation
Asoutlined above,plateletactivation followingthe addition of 2017-78i sassociated withatriphasicphosphorylation time courseofFcγ RIIA, Syk,LAT and PLC γ 2.Ineachcasetwowaves of phosphorylation separated byadephosphorylation phasei s observed,suggesting the actionsof bothk inasesand phosphatases.The inhibitory effectof PECAM-1 on ITAM-containing receptorsignalingpathways (32)and the recruitmentof protein tyrosine phosphatases,S HP-1 and SHP-2,top hosphorylated PECAM-1 (42-44) suggest the possibility thatPECAM-1 plays aroleinthisdephosphorylation phase.
Inthe currentstudy,2017-78causesthe rapid tyrosine phosphorylation of PECAM-1 in anIgG-dependentmanner (Fig.  4A) . Therefore,PECAM-1 activation likelyoccurs downstream of Fcγ RIIA cross-linking. PECAM-1 alsobecomesdephos- phorylated,howeverin contrast toFcγ RIIA, Syk,L AT,a nd PLCγ 2,P ECAM-1 remainsphosphorylated longerw ithin the lagphase (Fig. 4A) . PECAM-1 rephosphorylation isinhibited by eitherdepletion of IgGorpre-treatmentwithRGDS (Fig. 4A) , and isthereforedependenton α IIb β 3 engagement.
The protein tyrosine phosphataseSHP-1 co-precipitateswith PECAM-1 within the lagphase (Fig. 4B) . Incontrast thereisno detectable co-immunoprecipitation of SHP-2w ithPECAM-1 (datanotshown),whichsuggests thatSHP-1 isthe primary tyrosine phosphatasethatassociateswithPECAM-1 followingplateletactivation by2017-78and boundIgG.
SHP-1 isalsotyrosinephosphorylated;maximalphosphorylation occurs during the lagp hasef ollowed bydephosphorylation during aggregation (Fig. 4B) . Thus,thisphosphorylation time courseisoppositetothatobserved forFcγ RIIA, Syk,LAT, and PLC γ 2.Blocking aggregation withRGDS prevents SHP-1 dephosphorylation att he timepointcorresponding toaggregation,c onfirming arolef or α IIb β 3 and subsequentoutside-in signaling in SHP-1 dephosphorylation (Fig. 4B) . Therewasno detectable phosphorylation of SHP-2atanytime point(datanot shown).
α IIb β 3 mediatesprotein re-phosphorylation,TxA 2 release,densegranule secretionand phosphatidicacid formation Asshownabove,the re-phosphorylation of Fcγ RIIA, Syk,LAT, and PLC γ 2occurs simultaneouslyw ith2017-78-induced plateletaggregation. Toestablisharolefor α IIb β 3 -mediated outsidein signaling in thisprocess,platelets werep re-incubated with RGDS.Pretreatmentw ithRGDS abolished there-phosphorylation of Fcγ RIIA, Syk,L AT,a nd PLCγ 2 (Fig. 5A) ,a sw ellas TxA 2 release,densegranule secretion and PLCactivation (Table  1and Fig. 5C ),suggesting thatall of thesee vents occur downstreamof α IIb β 3 engagement.
Pre-incubation of platelets withaspirin decreases,but does notabolish,F c γ RIIA, Syk,L AT,a nd PLCγ 2phosphorylation (Fig. 5B) . However,densegranule secretion and PLCactivation areabolishedinthe presenceofaspirin (Fig.5C) . Takentogether, theseresults suggest that α IIb β 3 -mediated outside-insignaling leadstothe dephosphorylation of SHP-1,asmentioned above, whichm aypermitr e-phosphorylation of severalp roteinsin a signaling pathwaythatinducesTxA 2 release,whichinturnpotentiatesthe aggregation responsebypromoting densegranule secretion and PLCactivity.
Discussion
Thereisincreasing evidenceforanassociation between certain cardiovasculardiseasesand infectious organisms.Forexample it hasbeen estimated thatconventionalriskfactors (hypertension, smoking,obesity,hypercholesterolemia, geneticpredisposition) predictthe developmentof less thanhalf of the observed atheroscleroticplaques (45) . Consequently,severalnovel riskfactors for atherosclerosishavebeenp roposed,including platelethyperactivity (45) and infectious organisms (45, 46) . Similarly,ithas beensuggested thatlow-level bacteraemiasinitiateh ost responsesaltering coagulability,endothelialand vessel wall integrity and plateletfunction,and subsequentlyresultin atheroscleroticand thromboticevents (47) . Most studieshavefocusedon Gram-negativeorganism-derived lipopolysaccharide (LPS)acting topromotethe atheroscleroticprocess (48) ,howeverthe ability of S.sanguis toactivateplatelets hasbeen cited asasignificantcontributing factortocoronary heart disease (49) .
Specificstrainsof oralbacteriain the viridansgroupofstreptococcii nducep lateletactivation,b oth in vitro (8) (9) (10) and,in rabbits, in vivo (12, 13) ,supporting athrombogenicroleforthese strains.While severalstudieshaveaddressed possible bacterial ligandsand corresponding plateletreceptors mediating the interaction (10, 14, 50, 51) ,thespecificsignaling pathways triggered in platelets bybacterialchallenge havenotbeencharacterised.
Inthe presentstudy, S.sanguis strain 2017-78-induced plateletactivation wasassociated withthe tyrosinephosphorylation of the lowaffinity IgGreceptoron platelets,Fc γ RIIA.Thiscorrelateswithprevious studieswhereplatelets failedtorespondto S.sanguis strain NCTC7863 when plasmaisdepleted of IgG (18) and isconsistentwithFcγ RIIA playing afundamentalrole in S.sanguis -induced plateletaggregation. Fcγ RIIA phosphorylation initiated apathwayinvolving Srcfamilytyrosine kinases, Syk,a nd LAT, leading tothe phosphorylation of PLCγ 2.Activation of thispathwayisindependentof α IIb β 3 and thromboxane A 2 ,demonstrating thatitisanearlysignalingevent.Notsurprisingly,thispathwayissimilartothatevoked bydirectstimulation of Fcγ RIIA withanti-Fcγ RIIA antibodyand secondary crosslinkingantibodies (23, 41, 52) .
However,in the currentstudies,using optimalplatelettobacteriaratios,F c γ RIIA, Syk,L AT and PLC γ 2aree achsubsequentlydephosphorylated priort othe engagementof α IIb β 3 activation.Thiscontrasts withd irectFcγ RIIA cross-linking where,again usingoptimalconcentrationsof crosslinking secondary antibody (20, 26) ,the dephosphorylation of PLCγ 2 (26) and LAT(53)occursdownstreamof α IIb β 3 engagement.Taken togethert hesed atasuggest that,a lthough the earlys ignalling pathways evoked by2017-78arelikelymediated bythe action of IgGon Fcγ RIIA, therearesignificantdifferencesin the mechanismsof plateletactivation by S.sanguis and bydirectFcγ RIIA crosslinking.
Severalstudieshavesuggested thatPECAM-1 negatively regulatesplateletr esponsest oITAM-mediated signaling pathways,suchasthosestimulated bycollagen,Fc γ RIIA and glycoprotein Ib/V/IX (30) (31) (32) (33) 54) .Inthe presentstudy,PECAM-1 is rapidlytyrosine phosphorylated in responseto2017-78andre-mainsphosphorylated within the lagphase.The phosphorylation InterestinglyPECAM-1 recruits SHP-1,b ut notSHP-2,to the membrane,whichcontrasts previous studiesw hichsuggest thatSHP-2ist he preferred PECAM-1-associated phosphatase (42, (56) (57) (58) . The preferentialrecruitmentof SHP-1 observed in thiss tudyis,however,plausible.Firstly,previous studieshave recognizedSHP-1 asanegativeinfluenceonsignaling in haematopoieticc ells(59,60),whereasSHP-2isbelieved toe nhance cellsignaling.Secondly,directFcγ RIIA activationi nm yeloid cells(61)using cross-linking antibodiesleadst obothSHP-1 phosphorylation and its association withtyrosine phosphorylated Fcγ RIIA.Finally,substratespecificity maydictatewhich protein tyrosine phosphataseassociateswithPECAM-1. Frank etalrecentlydemonstrated thatSrcsubstratesaree fficiently dephosphorylated bySHP-1 (62) . Theinhibition of the S.sanguis -induced earlys ignalingp athwaybySrcfamilykinasei nhibitors implicatesacentralroleforthesekinases,and the substratesof Srcand otherrelated kinasesmaythereforebetargets of SHP-1. SykisalsoasubstrateofSHP-1 in Band Tcells (63) , and mayalsobeaSHP-1 substrateinplatelets sinceitco-precipitateswithSHP-1 (64) .
Thef unction of PECAM-1 dephosphorylation priort oaggregation isu nknown,howeveritislikelyt hatitattenuates SHP-1 recruitmenttherebyallowingthe proaggregatory signalling toproceed. Therephosphorylation of PECAM-1 during aggregation isinteresting and maybearesultof increased homophilicbinding,sincecell-cellcontactinduced bystirring alone leadstoalowdegree of PECAM-1 phosphorylation (37). Alternatively,a ggregation leadst oreleaseo fg ranule contents,a nd sincePECAM-1 ispresentin the membranesof α -granules(65), increased surfaceexpression of PECAM-1 maycontributetoits increased activation.
RGDS blockedthe rephosphorylation of Fcγ RIIA, Syk,LAT, and PLC γ 2,a nd the dephosphorylation of SHP-1,c onsistent withavitalrole for α IIb β 3 -mediated outside-insignalling.TxA 2 potentiatesoutside-in signaling asaspirin decreases,b ut does notabolish,thelatephosphorylation events.Howeverthe precise mechanismleading to α IIb β 3 activation in responseto S.sanguis isunknownand requiresfurtherstudy.
The currentstudysupportsarequirementforIgGin the plateletaggregation responseto S.sanguis (18) . Howeverthereare differencesbetweensignalling pathways engagedby S.sanguis and bythe directcrosslinking of Fcγ RIIA, and thesemayresult from the involvementof otherpathways.Forexample Fordetal haveshownthatinhibition,ordeletion,of complementproteins prevents aggregation in responseto S.sanguis strain NCTC7863 (17) .FurthermorerolesforGP Ib, whichhasbeenshowntobe essentialf orplatelet-S.sanguis adhesion (16),a nd the platelet aggregation-associated protein( PA AP),whichcontainsac ollagen-likedomain and isfoundonthe surfaceofaggregation-inducingstrainsof S.sanguis (66, 67) ,arealsopossible contributing factors tothe observed α IIb β 3 activation.Interestingly,there isprecedenceforadualactivation process.Inplateletactivation induced byanti-streptokinaseantibodies,b othFc receptorengagementandcleavage of the protease-activated receptor, PA R-1,areinvolved (68) in asimilarmannertothatoutlined in the currentstudy.
The activation of platelets by S.sanguis strain 2017-78i s therefored ependenton anumberof sequentialbiochemical events.IgGbound to S.sanguis interactwithFcγ RIIA stimulating asignaltransduction cascade including activation of the receptoritself,S rc-familykinases,S yk,L AT,a nd PLCγ 2. PECAM-1 phosphorylation and its association withSHP-1 appeartoplayanegativeregulatory role. Subsequentactivation of α IIb β 3 byanasyetundeterminedmechanisminducesSHP-1 dephosphorylation toovercome thisnegativeeffect,allowingasecond waveoftyrosinephosphorylation thatinducesTxA 2 release, whichisessentialforsecretion and aggregation.
